Alkermes
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.About ALKS
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.
CEORichard F. Pops
CEORichard F. Pops
Employees1,800
Employees1,800
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2011
Founded2011
Employees1,800
Employees1,800
ALKS Key Statistics
Market cap4.88B
Market cap4.88B
Price-Earnings ratio14.63
Price-Earnings ratio14.63
Dividend yield—
Dividend yield—
Average volume2.47M
Average volume2.47M
High today$30.23
High today$30.23
Low today$29.24
Low today$29.24
Open price$29.86
Open price$29.86
Volume1.12M
Volume1.12M
52 Week high$36.45
52 Week high$36.45
52 Week low$25.17
52 Week low$25.17
Stock Snapshot
With a market cap of 4.88B, Alkermes(ALKS) trades at $29.36. The stock has a price-to-earnings ratio of 14.63.
On 2025-11-30, Alkermes(ALKS) stock moved within a range of $29.24 to $30.23. With shares now at $29.36, the stock is trading +0.4% above its intraday low and -2.9% below the session's peak.
Trading volume for Alkermes(ALKS) stock has reached 1.12M, versus its average volume of 2.47M.
The stock's 52-week range extends from a low of $25.17 to a high of $36.45.
The stock's 52-week range extends from a low of $25.17 to a high of $36.45.
ALKS News
TipRanks 4d
Jefferies expects Avadel-Alkermes deal to closeJefferies lowered the firm’s price target on Avadel Pharmaceuticals (AVDL) to $22.50 from $23 and keeps a Hold rating on the shares as the firm expects the deal...
Analyst ratings
81%
of 16 ratingsBuy
81.3%
Hold
18.8%
Sell
0%
People also own
Based on the portfolios of people who own ALKS. This list is generated using Robinhood data, and it’s not a recommendation.